Vivos (RDGL) Revenue (2010 - 2025)

Vivos' (RDGL) quarterly Revenue came in at $24752.0 in Q4 2025, up 395.54% year-on-year from $4995.0 in Q4 2024, and up 1217.3% quarter-over-quarter from $1879.0 in Q3 2025.

Vivos (RDGL) Revenue (2010 - 2025) Analysis & Trends

Vivos has disclosed Revenue across 16 years of filings, most recently posting $24752.0 for Q4 2025.

  • Revenue for Q4 2025 came in at $24752.0, up 395.54% year-over-year; the trailing twelve-month figure through Dec 2025 was $68379.0 (up 144.25% YoY), and the FY2025 annual result was $68379.0, up 144.25% from the prior year.
  • Revenue came in at $24752.0 for Q4 2025 at Vivos, up from $1879.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $26748.0 in Q1 2025 to a low of $1879.0 in Q3 2025.
  • The 5-year median for Revenue is $6750.0 (2022), against an average of $10453.8.
  • Peak annual rise in Revenue reached 494.4% in 2025, while the deepest fall reached 62.42% in 2025.
  • Vivos' Revenue stood at $14887.0 in 2021, then slumped by 56.34% to $6499.0 in 2022, then rose by 7.71% to $7000.0 in 2023, then declined by 28.64% to $4995.0 in 2024, then surged by 395.54% to $24752.0 in 2025.
  • The last three Revenue figures came in at $24752.0 (Q4 2025), $1879.0 (Q3 2025), and $15000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 11.16 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 6.02 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 9.02 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 5.20 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 1.65 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 5.13 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 4.57 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 1.19 Bn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 1.59 Bn
10 Vivos - - -3,105.00 24,752.00

Historic Data

Download Data
DateValue
Dec 31, 2025 24,752.00
Sep 30, 2025 1,879.00
Jun 30, 2025 15,000.00
Mar 31, 2025 26,748.00
Dec 31, 2024 4,995.00
Sep 30, 2024 5,000.00
Jun 30, 2024 13,500.00
Mar 31, 2024 4,500.00
Sep 30, 2023 7,000.00
Jun 30, 2023 6,500.00
Mar 31, 2023 6,000.00
Dec 31, 2022 6,499.00
Sep 30, 2022 6,500.00
Jun 30, 2022 10,500.00
Mar 31, 2022 13,000.00
Sep 30, 2021 14,887.00
Sep 30, 2020 7,000.00
Dec 31, 2019 1,500.00
Sep 30, 2019 8,000.00
Mar 31, 2018 17,583.00